Danny Matthews
No más puestos en curso
Health Technology
Perfil
Danny Matthews worked as a Director of Investor Relations and Communications at BELLUS Health, Inc.
Antiguos cargos conocidos de Danny Matthews.
| Empresas | Cargo | Fin |
|---|---|---|
| BELLUS HEALTH | Contacto de Relaciones con Inversores | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
BELLUS Health, Inc.
 BELLUS Health, Inc. Pharmaceuticals: MajorHealth Technology BELLUS Health, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of cough hypersensitivity and other hypersensitization disorders. Its product BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch. The company was founded on June 17, 1993 and is headquartered in Laval, Canada. | Health Technology |
- Bolsa de valores
- Insiders
- Danny Matthews
